The following article by Steve MacDonald has been republished with permission from GraniteGrok.
In a hearing Tuesday afternoon, the New Hampshire House Committee on Health and Human Services and Elderly Affairs will hear testimony on HB1022. The Bill would allow pharmacists to “dispense ivermectin to persons in this state without a prior prescription.”
As previously reported here and everywhere that is not the legacy media, Ivermectin is a safe and effective treatment for many conditions, not the least of which is SARS CoV2. Ivermectin has been so remarkable at helping human beings that its creator won a Nobel Prize.
If we’d had widespread access and promotion early on, and we know that the Fauci-medical-industrial complex knew it would help as early as March of 2020, it could have saved thousands of lives.
We got the opposite, and many people died and are still dying unnecessarily.
Here’s a look at the legislation:
I. In this section, “standing order” means a written and signed protocol authored by one or more physicians licensed under RSA 329:12 or one or more advanced practice registered nurses licensed under RSA 326-B:18. Such agreement shall specify a protocol allowing the pharmacist licensed under RSA 318:18 to dispense Ivermectin under the delegated prescriptive authority of the physician or APRN, specify a mechanism to document screening performed and the prescription in the patient’s medical record, and include a plan for evaluating and treating adverse events. Any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice.
II. Licensed pharmacists following standing orders may dispense Ivermectin to persons in this state without a prior prescription.
III. A pharmacist, pharmacy, physician, or APRN issuing or following standing orders shall be prohibited from seeking personal financial benefit by participating in any incentive-based program or accepting any inducement that influences or encourages therapeutic or product changes or the ordering of tests or services.
IV. The pharmacist shall provide each recipient of Ivermectin pursuant to this section with a standardized information sheet written in plain language, which shall include, but is not limited to, the importance of follow-up care, and health care referral information. Nothing on the information sheet shall discourage the recipient from using Ivermectin for the treatment of COVID-19.
This effectively removes existing barriers for people to get access to Ivermectin. It also provides protection from bureaucratic intimidation and harassment tactics directed at doctors, APRNs, and Pharmacists in New Hampshire.